Randomized, Ph3 Clinical Study Comparing Vusolimogene Oderparepvec in Combination With Nivolumab Vs Treatment of Physician's Choice in Patients With Advanced Melanoma That Progressed on Anti-PD-1 and Anti-CTLA-4 Containing Treatment

Bookmark
Investigational drug late phase More information Active drug More information Moderate burden on patient More information

Trial Details

Sponsor: Replimune Inc. (industry)

Phase: 3

Start date: July 11, 2024

Planned enrollment: 400

Trial ID: NCT06264180
Copy trial ID
More trial details at ClinicalTrials.gov More info

chevron Show Summary from Sponsor

Investigational Drug AI Analysis

chevron Show for: RP1 (Vusolimogene oderparepvec)

TrialFetch AI Analysis

Goal: Determine whether vusolimogene oderparepvec (VO) plus nivolumab improves survival compared with physician’s choice treatment in advanced cutaneous melanoma after checkpoint inhibitor therapy.

Patients: Patients aged 12 years or older with unresectable stage IIIB–IV cutaneous melanoma, at least one measurable injectable tumor, and progression after anti-PD-1 therapy and anti-CTLA-4 therapy, given together or sequentially. Patients who are not candidates for anti-CTLA-4 therapy may also enroll. Key restrictions include more than two prior systemic treatment lines, active CNS metastases, and LDH greater than twice the upper limit of normal.

Design: Randomized, multicenter, open-label, controlled trial comparing VO plus nivolumab with physician’s choice treatment.

Treatments: The experimental arm receives intratumoral VO plus nivolumab. VO is a modified herpes simplex virus type 1 designed to replicate in tumors and express GM-CSF and a fusogenic protein to promote tumor-cell destruction and antitumor immunity; nivolumab blocks PD-1. In the prior single-arm IGNYTE study of the combination after anti-PD-1 progression, the published objective response rate was 32.9%, but the study could not establish VO’s contribution to that response. The comparator is physician’s choice of nivolumab plus relatlimab, anti-PD-1 monotherapy with nivolumab or pembrolizumab, or single-agent chemotherapy.

Outcomes: The primary endpoint is overall survival from randomization. Secondary endpoints include RECIST v1.1 progression-free survival and objective response rate; assessments are planned through approximately January 2029.

Burden on patient: Likely moderate. The experimental arm requires visits for intratumoral injections as well as nivolumab administration, with imaging and safety monitoring expected in a melanoma trial. Injectable tumors may make travel and procedures more demanding than systemic treatment alone. The supplied information does not specify mandatory research biopsies, intensive pharmacokinetic sampling, or visit frequency, so the additional burden cannot be estimated precisely.

Last updated: Sep 2026

Eligibility More information

Caution: ClinicalTrials.gov appears to have newer eligibility criteria than the version saved here. Review the current criteria in ClinicalTrials.gov.

chevron Show Criteria

Sites (73)

Sort by distance to:
Clear

CHU Nice

Nice, 06200, France

No email / No phone

Status: Recruiting

CHU de Lille

Lille, 59000, France

No email / No phone

Status: Recruiting

Hopital de La Timone

Marseille, 13005, France

No email / No phone

Status: Recruiting

Hospices Civils de Lyon (HCL) - Centre Hospitalier Lyon-Sud

Pierre-Bénite, 69495, France

No email / No phone

Status: Recruiting

Hôpital Saint Louis - AP-HP

Paris, 75010, France

No email / No phone

Status: Recruiting

Institut Gustave Roussy

Villejuif, 94800, France

No email / No phone

Status: Recruiting

Charité - Universitätsmedizin Berlin

Berlin, 10117, Germany

No email / No phone

Status: Recruiting

Helios Klinik

Erfurt, 99089, Germany

No email / No phone

Status: Recruiting

Universitatsklinikum Mainz Hautklinik und Poliklinik

Mainz, 55131, Germany

No email / No phone

Status: Recruiting

University of Kiel

Kiel, 24105, Germany

No email / No phone

Status: Recruiting

Universitätsklinikum Essen

Essen, 45147, Germany

No email / No phone

Status: Recruiting

Universitätsklinikum Hospital Heidelberg

Heidelberg, 69120, Germany

No email / No phone

Status: Recruiting

Universitätsklinikum Medical Center

Hamburg, 20246, Germany

No email / No phone

Status: Recruiting

Universitätsklinikum of Tübingen

Tübingen, 72076, Germany

No email / No phone

Status: Recruiting

Maria Sklodowska-Curie National Research Institute of Oncology

Warsaw, 02-781, Poland

No email / No phone

Status: Recruiting

Uniwersyteckie Centrum Kliniczne

Gdansk, 80-214, Poland

No email / No phone

Status: Recruiting

Clinica Universidad de Navarra - Madrid

Madrid, 28027, Spain

No email / No phone

Status: Recruiting

Clinica Universidad de Navarra - Pamplona

Pamplona, 31008, Spain

No email / No phone

Status: Recruiting

Hospital Clinic de Barcelona

Barcelona, 08036, Spain

No email / No phone

Status: Recruiting

Hospital Clínico Universitario Virgen de la Arrixaca

El Palmar, 30120, Spain

No email / No phone

Status: Recruiting

Hospital Universitari Vall d'Hebron

Barcelona, 08035, Spain

No email / No phone

Status: Recruiting

Hospital Universitario 12 de Octubre

Madrid, 28041, Spain

No email / No phone

Status: Recruiting

Clatterbridge Cancer Centre NHS Foundation Trust

Liverpool, L7 8YA, United Kingdom

No email / No phone

Status: Recruiting

The Royal Marsden NHS Foundation Trust

London, SW3 6JJ, United Kingdom

No email / No phone

Status: Recruiting

Banner MD Anderson Cancer Center

Gilbert, Arizona, 85234, United States

No email / No phone

Status: Recruiting

San Francisco Oncology Associates

San Francisco, California, 94115, United States

No email / No phone

Status: Recruiting

Stanford Cancer Institute

Palo Alto, California, 94304, United States

No email / No phone

Status: Recruiting

Sutter Medical Group

Sacramento, California, 95816, United States

No email / No phone

Status: Recruiting

The Angeles Clinic and Research Institute

Los Angeles, California, 90025, United States

No email / No phone

Status: Recruiting

UC Irvine Health, Chao Family Comprehensive Cancer Center

Orange, California, 92868, United States

No email / No phone

Status: Recruiting

UC San Diego Moores Cancer Center

La Jolla, California, 92037, United States

No email / No phone

Status: Recruiting

UCLA Department of Medicine - Hematology/Oncology

Los Angeles, California, 90095, United States

No email / No phone

Status: Recruiting

UCSF Helen Diller Family Comprehensive Cancer Center

San Francisco, California, 94143, United States

No email / No phone

Status: Recruiting

USC Norris Comprehensive Cancer Center

Los Angeles, California, 90033, United States

No email / No phone

Status: Recruiting

The Melanoma and Skin Cancer Institute

Englewood, Colorado, 80113, United States

No email / No phone

Status: Recruiting

University of Colorado Hospital - Anschutz Cancer Pavilion

Aurora, Colorado, 80045, United States

No email / No phone

Status: Recruiting

MedStar Washington Hospital Center

Washington D.C., District of Columbia, 20010, United States

No email / No phone

Status: Recruiting

Memorial Cancer Institute at Memorial Regional Hospital

Hollywood, Florida, 33021, United States

No email / No phone

Status: Recruiting

Moffitt Cancer Center

Tampa, Florida, 33612, United States

No email / No phone

Status: Recruiting

Winship Cancer Institute, Emory University

Atlanta, Georgia, 30322, United States

No email / No phone

Status: Recruiting

Northwestern Memorial Hospital

Chicago, Illinois, 60611, United States

No email / No phone

Status: Recruiting

University of Iowa

Iowa City, Iowa, 52242, United States

No email / No phone

Status: Recruiting

University of Kansas Cancer Center

Westwood, Kansas, 66205, United States

No email / No phone

Status: Recruiting

University of Louisville Brown Cancer Center

Louisville, Kentucky, 40202, United States

No email / No phone

Status: Recruiting

Corewell Health

Grand Rapids, Michigan, 49503, United States

No email / No phone

Status: Recruiting

Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion)

Detroit, Michigan, 48202, United States

No email / No phone

Status: Recruiting

University of Minnesota

Minneapolis, Minnesota, 55455, United States

No email / No phone

Status: Recruiting

Dartmouth Hitchcock Cancer Center

Lebanon, New Hampshire, 03756, United States

No email / No phone

Status: Recruiting

Hackensack University Medical Center

Hackensack, New Jersey, 07601, United States

No email / No phone

Status: Recruiting

MD Anderson Cancer Center at Cooper

Camden, New Jersey, 08103, United States

No email / No phone

Status: Recruiting

Morristown Medical Center - Atlantic Health System

Morristown, New Jersey, 07960, United States

No email / No phone

Status: Recruiting

Montefiore Medical Center

The Bronx, New York, 10461, United States

No email / No phone

Status: Recruiting

Northwell Health, R.J. Zuckerberg Cancer Center

Lake Success, New York, 11042, United States

No email / No phone

Status: Recruiting

Roswell Park Cancer Institute

Buffalo, New York, 14263, United States

No email / No phone

Status: Recruiting

Stony Brook University Cancer Center

Stony Brook, New York, 11794, United States

No email / No phone

Status: Recruiting

Duke Cancer Center

Durham, North Carolina, 27710, United States

No email / No phone

Status: Recruiting

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27514, United States

No email / No phone

Status: Recruiting

The Ohio State University- Martha Morehouse Tower

Columbus, Ohio, 43210, United States

No email / No phone

Status: Recruiting

Fox Chase Cancer Center

Philadelphia, Pennsylvania, 19111, United States

No email / No phone

Status: Recruiting

Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States

No email / No phone

Status: Recruiting

UPMC

Pittsburgh, Pennsylvania, 15232, United States

No email / No phone

Status: Recruiting

Rhode Island Hospital

Providence, Rhode Island, 02903, United States

No email / No phone

Status: Recruiting

University of Tennessee

Knoxville, Tennessee, 37920, United States

No email / No phone

Status: Recruiting

West Cancer Center and Research Institute

Germantown, Tennessee, 38138, United States

No email / No phone

Status: Recruiting

Texas Oncology

Dallas, Texas, 75246, United States

No email / No phone

Status: Recruiting

The University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States

No email / No phone

Status: Recruiting

University of Texas Southwestern Medical Center

Dallas, Texas, 75390, United States

No email / No phone

Status: Recruiting

Huntsman Cancer Institute

Salt Lake City, Utah, 84112, United States

No email / No phone

Status: Recruiting

Intermountain Health

Murray, Utah, 84107, United States

No email / No phone

Status: Recruiting

St. George Regional Hospital

St. George, Utah, 84790, United States

No email / No phone

Status: Recruiting

University of Vermont Medical Center

Burlington, Vermont, 05401, United States

No email / No phone

Status: Recruiting

West Virginia University

Morgantown, West Virginia, 26506, United States

No email / No phone

Status: Recruiting

Advocate Lutheran General Hospital

Park Ridge, Illinois, 60068, United States

No email / No phone

Status: Withdrawn

Back to trials list